SULGAN-N supp 20 pce

7680487250766 CH-48725 C05AD01 02.09.1.
SULGAN-N supp 20 pce
google

Details

Product number
4872504
CPT
-
Packaging group
20
Unit
Suppositorien
Composition
lidocainum 4.32 mg, camphora racemica 20 mg, levomentholum 10 mg, propylenglycolum, alcohol 2,4-dichlorobenzylicus, triclosanum, excipiens pro suppositorio.

Articles (1)

Sulgan N, Suppositorien
Suppositorien
20
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
lidocainum
4.32 MG Substance Wirkstoff (Principe actif)
(N/A)
4.32 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
camphora racemica
20.0 MG Substance Wirkstoff (Principe actif)
levomentholum
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
adeps solidus
- Substance HNIDK
zinci oxidum
- Substance HNIDK
ethylis linolas
- Substance HNIDK
ethylis linolenas
- Substance HNIDK
aluminii chloridum/hydroxidum
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
propylenglycolum
- Substance HNIDK
(N/A)
- Substance HIMDK
alcohol 2,4-dichlorobenzylicus
- Substance HIMDK
(N/A)
- Substance HIMDK
triclosanum
- Substance HIMDK

Authorization holder

Doetsch Grether AG

4051 Basel

Authorization information

Swissmedic authorization number
48725
Drug name
Sulgan N, Suppositorien
Galenic form
SUPP
ATC Code
C05AD01
Authorization status
Z
Dispensation category
D
First authorization
04/06/1987
Authorization expiration date
31/12/9999
IT number
02.09.1.
Domain
Human medicine
Field of application
Beschwerden bei Hämorrhoiden

Packaging details

Description (FR)
SULGAN-N supp 20 pce
Description (DE)
SULGAN-N Supp 20 Stk
Market launch
25/09/2009
Narcotic (BTM)
No

Other packaging sizes

SULGAN-N supp 10 pce
10 SUP
View